Harmony Biosciences Shares Rebound From Friday's 52-Week Low
By Chris Wack Harmony Biosciences Holdings shares rebounded 9% to $23.04 from Friday's drop, when the company said its Phase 3 study missed the primary...
Source: marketwatch.com
Page 47 - Service Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Service Testing Today - Breaking & Trending Today
Omeros Shares Cut Nearly in Half as it Discontinues Trial
By Will Feuer Shares of Omeros were cut nearly in half after the company said it is discontinuing its late-stage clinical trial evaluating its narsoplimab...
Source: marketwatch.com
Annovis Bio Shares Up 16% as Alzheimer Study Is Set to Continue
By Adam L. Cataldo Annovis Bio's shares gained after the company said an independent statistical group concluded that its Phase 2/3 study could continue as...
Source: marketwatch.com
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.
Source: marketwatch.com
Faron Says Myeloid Leukemia Drug Showing Consistent Positive Results
By Michael Susin Faron Pharmaceuticals Oyj said that study data from its acute myeloid leukemia treatment, Bexmarilimab, showed positive results. The...
Source: marketwatch.com